JG

Jyoti Gandhi

Director DIN 02288131
DIN 02288131 First appointment Sep 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyoti Gandhi

Data last updated:

Jyoti Gandhi was a Director at Raghav Immigration & Education Consultancy Private Limited (from 2008) and Managing Director at Day & Days Pharmaceuticals Private Limited (from 2009).

DIN 02288131
First Appointment 17 Sep 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20082008Strike Off
Managing Director02 Sep 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Raghav Immigration & Education Consultancy Private Limited
Day & Days Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyoti Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Gandhi

Jyoti Gandhi was first appointed on 17 Sep 2008 as Director at Raghav Immigration & Education Consultancy Private Limited. The most recent appointment on record is 02 Sep 2009 at Day & Days Pharmaceuticals Private Limited.

Jyoti Gandhi held 2 earlier board appointments: Raghav Immigration & Education Consultancy Private Limited (Director, from 17 Sep 2008); Day & Days Pharmaceuticals Private Limited (Managing Director, from 02 Sep 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available